BE716437A - - Google Patents

Info

Publication number
BE716437A
BE716437A BE716437A BE716437A BE716437A BE 716437 A BE716437 A BE 716437A BE 716437 A BE716437 A BE 716437A BE 716437 A BE716437 A BE 716437A BE 716437 A BE716437 A BE 716437A
Authority
BE
Belgium
Prior art keywords
emi
drug
fraction
subject
treatment
Prior art date
Application number
BE716437A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE716437A publication Critical patent/BE716437A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE716437A 1967-07-05 1968-06-12 BE716437A (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR113105A FR6776M (no) 1967-07-05 1967-07-05

Publications (1)

Publication Number Publication Date
BE716437A true BE716437A (no) 1968-11-04

Family

ID=8634474

Family Applications (1)

Application Number Title Priority Date Filing Date
BE716437A BE716437A (no) 1967-07-05 1968-06-12

Country Status (3)

Country Link
BE (1) BE716437A (no)
FR (1) FR6776M (no)
NL (1) NL6809514A (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK634186A (da) * 1986-01-02 1987-07-03 American Cyanamid Co Proteolipidforbindelser, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
NL6809514A (no) 1969-01-07
FR6776M (no) 1969-03-10

Similar Documents

Publication Publication Date Title
FR2914188A1 (fr) Nouvelle composition a base d'oxime de cholest-4-en-3-one
EP0436650A1 (fr) Phases lamellaires lipidiques hydratees ou liposomes a base d'ecdysteroides.
JPH0455168B2 (no)
BE895724A (fr) Nouvelle utilisation therapeutique de la dihydrocyclosporine d
EP1102586B1 (fr) Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sclerose laterale amyotrophique
FR2492260A1 (fr) Composition pharmaceutique pour l'administration orale contenant le facteur de coagulation viii
US4677099A (en) Medical processes employing a novel lipid fraction
FR2885050A1 (fr) Composition amincissante a base d'extraits de cacao.
CA2312856C (fr) Utilisation d'extraits de ginkgo biloba pour preparer un medicament
FR2744915A1 (fr) Composition cosmetique a base de cellules indifferenciees de ginkgo biloba
JP2023145593A (ja) アツバノリ属抽出物及びその使用
BE716437A (no)
EP3242674B1 (fr) Compositions contenant de la curcumine à biodisponibilité améliorée
FR2619009A1 (fr) Agent anti-hyperlipemique
FR2591890A1 (fr) Composition a usage therapeutique comprenant des composes organo-silicies
CN110420270A (zh) 一种含有山茶油和鱼油的功能性组合物及其应用
FR2467598A1 (fr) Composition dermatologique contenant un ou plusieurs triglycerides et son application au traitement de la peau vivante
EP3041486A1 (fr) Utilisation de propolis pour lutter contre les effets secondaires des chimiotherapies
TWI815349B (zh) 山竹果殼萃取物用於製備促進糖尿病傷口癒合的藥物的用途
FR2756740A1 (fr) Medicament contenant un adrenocorticosteroide, destine au traitement de l'hircisme
JP4473968B2 (ja) 血球流動性改善剤
FR2839887A1 (fr) Nouvelles compositions nutraceutiques et pharmaceutiques et leurs utilisations
FR2635462A1 (fr) Preparation medicamenteuse a base d'extrait d'ortie urtica kiovensis (rogiwicz), leur utilisation pour le traitement de tumeurs, et procedes de fabrication
FR2884425A1 (fr) Composition pharmaceutique destinee a soigner le psoriasis
FR2709964A1 (fr) Compositions pharmaceutiques antivirales proposées dans le traitement du SIDA et de l'Herpès.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: GAILLARD JEAN-PIERRE

Effective date: 19880612